Back
Axsome Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
AXSM
Sponsored
MarketBeat Alert: Strong sell signal just issued for these 20 stocks
Go here now to get free instant access to all 20 stocks to sell.
Sell
35
AXSM
Axsome Therapeutics
Last Price:
67.87
Seasonality Move:
22.31%
7 Day Trial
ALL ACCESS PASS
$
7
DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon
Discover our top DeFi pick for potentially massive gains now (before it's too late).Axsome Therapeutics Price Quote
$67.87
+2.13 (+3.24%)
(Updated: April 19, 2024 at 4:10 PM ET)
Axsome Therapeutics Key Stats
Sell
35
Axsome Therapeutics (AXSM)
is a Sell
Day range:
$65.61 - $70.08
52-week range:
$55.02 - $98.40
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
11.03
P/B ratio:
16.31%
Volume:
770.1K
Avg. volume:
716.7K
1-year change:
-9.76%
Market cap:
$3.1B
Revenue:
$270.6M
EPS:
$-5.2
How Much Does Axsome Therapeutics Make?
-
How Much Are Axsome Therapeutics's Sales Annually?
AXSM Revenues are $270.6M -
How Much Profit Does Axsome Therapeutics's Make A Year?
AXSM net income is -$239.2M
Is Axsome Therapeutics Growing As A Company?
-
What Is Axsome Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 1.94% -
What Is Axsome Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Axsome Therapeutics Stock Price Performance
-
Did Axsome Therapeutics Stock Go Up Last Month?
Axsome Therapeutics share price went down by -9.37% last month -
Did AXSM's Share Price Rise Over The Last Year?
AXSM share price fell by -9.76% over the past 1 year
What Is Axsome Therapeutics 52-Week High & Low?
-
What Is Axsome Therapeutics’s 52-Week High Share Price?
Axsome Therapeutics has traded as high as $98.40 over the past 52 weeks -
What Is Axsome Therapeutics’s 52-Week Low Share Price?
Axsome Therapeutics has traded as low as $55.02 over the past 52 weeks
Axsome Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Axsome Therapeutics?
-
How Much Debt Does Axsome Therapeutics Have?
Total long term debt quarterly is $178.1M -
How Much Cash Does Axsome Therapeutics Have?
Cash and short term investments quarterly total is $386.2M -
What Is Axsome Therapeutics’s Book Value Per Share?
Book value per share is 4.03
Is Axsome Therapeutics Cash Flow Positive?
-
What Is AXSM Cash Flow From Operations?
Cash flow from operations (TTM) is -$145.1M -
What Is Axsome Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $331M -
What Is Axsome Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$582K
Axsome Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
AXSM return on invested capital is -68.95% -
What Is Axsome Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -47.44% -
What Is AXSM Return On Equity?
ROE is a measure of profitability and is -124.52%
Axsome Therapeutics Earnings Date & Stock Price
-
What Is Axsome Therapeutics's Stock Price Today?
A single share of AXSM can be purchased today for 65.74 -
What Is Axsome Therapeutics’s Stock Symbol?
Axsome Therapeutics trades on the nasdaq under the ticker symbol: AXSM -
When Is Axsome Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Axsome Therapeutics is scheduled on May 6, 2024 -
When Is AXSM's next ex-dividend date?
Axsome Therapeutics's next ex-dividend date is April 19, 2024 -
How To Buy Axsome Therapeutics Stock?
You can buy Axsome Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Axsome Therapeutics Competitors
-
Who Are Axsome Therapeutics's Competitors?
Below is a list of companies who compete with Axsome Therapeutics or are related in some way:
Axsome Therapeutics Dividend Yield
Data Unavailable
Axsome Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -74.83% |
Revenue: | 193.51% | 3.61% |
Analyst Recommendations
Buy Recommendations: | 11 |
---|---|
Hold Recommendations: | 2 |
Sell Recommendations: | 0 |
Price Target: | 121.13 |
Upside from Last Price: | 84.25% |